Double Bond Pharmaceutical Overview
- Founded
-
2014
- Status
-
Public
- Employees
-
10
- Stock Symbol
-
DBP B
- Investments
-
1
- Share Price
-
$0.03
- (As of Thursday Closing)
Double Bond Pharmaceutical General Information
Description
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
SAT
Primary Office
- Virdings allé 32B
- 754 50 Uppsala
- Sweden
Double Bond Pharmaceutical Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.03 | $0.03 | $0.03 - $0.17 | $1.86M | 63.3M | 56.5K |
Double Bond Pharmaceutical Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 1,379 | 2,836 | 10,834 | 8,934 |
| Revenue | 131 | 111 | 126 | 26 |
| EBITDA | (487) | (1,058) | (1,911) | (842) |
| Net Income | (514) | (1,078) | (1,921) | (827) |
| Total Assets | 2,233 | 3,072 | 2,778 | 961 |
| Total Debt | 0 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Double Bond Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Double Bond Pharmaceutical Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approac
Drug Discovery
Uppsala, Sweden
10
As of 2021
00000
0.000
0000-00-00
00000000
00000
000000
s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000 000000000
Barcelona, Spain
00
As of 0000
0000
000000000000
0000
000000
at. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla par
000000000000000
Foster City, CA
00000
As of 0000
00.000
000000000
00.000
Add Comparison
Double Bond Pharmaceutical Competitors (11)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ability Pharma | Venture Capital-Backed | Barcelona, Spain | 00 | 0000 | 000000000000 | 0000 |
| 000000 00000000 | Formerly VC-backed | Foster City, CA | 00000 | 00.000 | 000000000 | 00.000 |
| 000000000 | Formerly VC-backed | South San Francisco, CA | 00000 | 000.00 | 0000000000 | |
| 000000000 000000 | Venture Capital-Backed | Boston, MA | 00 | 00000 | 0000000000 0 | 00000 |
| 00 000000000000 | Formerly VC-backed | Durham, NC | 000 | 00000 | 000000 - 000 | 00000 |
Double Bond Pharmaceutical Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Igor Lokot Ph.D | Chief Executive Officer, Board Member & Founder |
Double Bond Pharmaceutical Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 00000 00.0 | Double Bond Pharmaceutical | Chief Executive Officer, Board Member & Founder | 000 0000 |
Double Bond Pharmaceutical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Double Bond Pharmaceutical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Double Bond Pharmaceutical Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 01-Oct-2015 | 000000000 | Buildings and Property |